financetom
Business
financetom
/
Business
/
EU ready to respond to U.S. on trade tariffs, says Germany's Scholz
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
EU ready to respond to U.S. on trade tariffs, says Germany's Scholz
Mar 30, 2025 9:38 AM

BERLIN (Reuters) - Europe wants to cooperate with the United States but the EU is ready to respond as one if Washington leaves it no choice by imposing tariffs on steel and aluminium, German Chancellor Olaf Scholz said on Sunday.

Speaking at the opening of the Hanover industrial trade fair which this year has Canada as its partner country, Scholz also insisted that Canada is an independent country.

U.S. President Donald Trump has mused about annexing Canada and referred to the country as the 51st U.S. state.

"We stand by your side!" Scholz said, adding: "Canada is not a state that belongs to anyone else. Canada is a proud, independent nation."

Addressing Trump's plans to introduce tariffs, Scholz said his answer to "my country first" policies was more free trade, greater competitiveness and more technological sovereignty.

Scholz argued that Europe was not naive but also not weak, and said trade wars hurt all sides.

"So I say to the United States: Europe's goal remains cooperation. But if the U.S. leaves us no choice, such as with the tariffs on steel and aluminium, we as the EU will react as one".

(Reporting by Andreas Rinke; Writing by Madeline Chambers; Editing by Thomas Seythal)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Alto Neuroscience Starts Phase 2 Trial of ALTO-203 in Major Depressive Disorder Patients
Alto Neuroscience Starts Phase 2 Trial of ALTO-203 in Major Depressive Disorder Patients
Apr 3, 2024
11:15 AM EDT, 04/03/2024 (MT Newswires) -- Alto Neuroscience ( ANRO ) said Wednesday it has started a phase 2 study of ALTO-203 in major depressive disorder patients. Alto said it expects to enroll about 60 adult participants with MDD and anhedonia, with top-line data expected in H1 of 2025. The company said ALTO-203 showed a favorable tolerability profile across...
Factbox-US, Canadian companies kick off 2024 with layoffs
Factbox-US, Canadian companies kick off 2024 with layoffs
Apr 3, 2024
(Reuters) -Companies in the United States and Canada have kicked off 2024 with thousands of job cuts across sectors, signaling that the spate of layoffs seen in 2023 could persist as they scramble to rein in costs. While hopes of a soft landing have grown in recent months, companies continue to be cautious as the outlook on rate cuts by...
Baker Hughes Wins Contract to Supply Gas Turbine-Driven Compressor Trains to Snam
Baker Hughes Wins Contract to Supply Gas Turbine-Driven Compressor Trains to Snam
Apr 3, 2024
11:17 AM EDT, 04/03/2024 (MT Newswires) -- Baker Hughes ( BKR ) said Wednesday it won a contract in a public tender to supply three gas turbine-driven compressor trains to Snam, a European operator in natural gas transportation, storage and regasification. The trains are for a new gas compressor station in Sulmona, Italy, Baker Hughes ( BKR ) said. Price:...
Merck, Daiichi Sankyo Dose First Person in Phase 2/3 Trial of Raludotatug Deruxtecan to Treat Ovarian Cancer
Merck, Daiichi Sankyo Dose First Person in Phase 2/3 Trial of Raludotatug Deruxtecan to Treat Ovarian Cancer
Apr 3, 2024
11:15 AM EDT, 04/03/2024 (MT Newswires) -- Merck ( MRK ) and Daiichi Sankyo said Wednesday they have dosed the first patient in a phase 2/3 trial assessing the efficacy and safety of investigational drug raludotatug deruxtecan to potentially treat ovarian cancer resistant to platinum-based chemotherapy. The second phase of the study is being done to establish the dose of...
Copyright 2023-2025 - www.financetom.com All Rights Reserved